| Description |
1 online resource (xiii, 279 pages) |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Bibliography |
Includes bibliographical references and index. |
| Contents |
Front Cover -- Dihydropyrimidinones as Potent Anticancer Agents -- Copyright Page -- Contents -- List of contributors -- 1 Introduction of dihydropyrimidinones: a medicinal chemistry perspective -- 1.1 Introduction -- 1.2 History -- 1.3 Separation of isomers -- 1.4 Synthesis -- 1.4.1 Chemistry and biological activities -- 1.4.2 New derivative: biphenyl dihydropyrimidinone -- 1.5 Future perspective -- 1.6 Conclusion -- References -- 2 Synthetic strategies of dihydropyrimidinones -- 2.1 Introduction -- 2.2 Synthetic strategies for dihydropyrimidinones |
|
2.2.1 Classical methods to synthesize dihydropyrimidinones -- 2.2.2 Nonclassical methods to synthesize dihydropyrimidinones -- 2.2.2.1 Microwave-assisted synthesis -- 2.2.2.2 Ultrasonication-assisted synthesis -- 2.2.2.3 Synthesis using ionic liquids as catalysts -- 2.2.2.4 Synthesis using nanomaterial-assisted catalysts -- 2.2.2.5 Synthesis under green conditions and chiral catalysts -- 2.2.2.6 Synthesis using miscellaneous strategies -- 2.3 Conclusion -- References -- 3 Biological activities of dihydropyrimidinones -- 3.1 Introduction -- 3.1.1 Antiinflammatory activity |
|
4.2 Synthetic strategies -- 4.3 Pharmacological potential of dihydropyrimidinones -- 4.3.1 Antifilarial activity -- 4.3.2 Antitubercular activity -- 4.3.3 Antihypertensive activity -- 4.3.4 Antibacterial activity -- 4.3.5 Anticancer activity -- 4.3.6 Antiinflammatory activity -- 4.3.7 Anti-HIV -- 4.3.8 Analgesic activity -- 4.3.9 Antifungal activity -- 4.3.10 Antihyperglycemic activity -- 4.3.11 Antisevere acute respiratory syndrome activity -- 4.3.12 Antioxidant activity -- 4.3.13 Anticonvulsant activity -- 4.3.14 Anti-Alzheimer's activity -- 4.3.15 Antihepatitis activity -- 4.4 Conclusion |
|
Acknowledgment -- Conflict of interest -- Funding -- References -- 5 Dihydropyrimidinones scaffold and potential anticancer targets -- 5.1 Introduction -- 5.2 Biological activities -- 5.2.1 Anticancer properties -- 5.2.2 Dihydropyrimidin-2(1H)-one (or thione) scaffolds potent against different cancers -- 5.2.2.1 Diarylpyrazole-ligated dihydropyrimidinones are potent scaffolds against breast cancer -- 5.2.2.1.1 Dihydropyrimidinone-based scaffolds are effective against breast cancer -- 5.2.2.1.2 DHPM-based scaffolds block kinesin Eg5 |
| Note |
Description based on online resource; title from digital title page (viewed on September 21, 2023). |
| Subject |
Antineoplastic agents -- Therapeutic use.
|
|
Dihydropyridine -- Therapeutic use.
|
|
Anticancéreux -- Emploi en thérapeutique.
|
|
Dihydropyridines -- Emploi en thérapeutique.
|
|
Antineoplastic agents -- Therapeutic use.
(OCoLC)fst00810609
|
| Added Author |
Bhat, Mashooq Ahmad, editor.
|
|
Rehman. Muneeb U., editor.
|
|
Verma, Amita, editor.
|
| Other Form: |
Print version: 9780443153044 |
|
Print version: 0443190941 9780443190940 (OCoLC)1360286365 |
| ISBN |
9780443153044 electronic book |
|
0443153043 electronic book |
|
9780443190940 |
|
0443190941 |
| Standard No. |
AU@ 000075034976 |
|
AU@ 000075110206 |
|
AU@ 000075018364 |
|
